CANDRIAM S.C.A. – Halozyme Therapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$25.84M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +12.22% | 71.17K shares | 219K | $39.54 | 653.67K |
| Q2 2022 | share | Decrease | -17.38% | -122.50K shares | -2.48M | $44 | 582.49K |
| Q1 2022 | share | Decrease | -0.01% | -73 shares | -238K | $39.88 | 705.00K |
| Q4 2021 | share | Increase | +1.02% | 7.1K shares | -41K | $40.32 | 705.07K |
| Q3 2021 | share | Increase | +27.15% | 149.04K shares | 3.46M | $40.68 | 697.97K |
| Q2 2021 | share | Decrease | -25.19% | -184.81K shares | -5.17M | $45.41 | 548.93K |
| Q1 2021 | share | Decrease | -0.00% | -12 shares | -1.23M | $41.69 | 733.74K |
| Q4 2020 | share | Decrease | -29.88% | -312.71K shares | 3.83M | $42.71 | 733.75K |
| Q3 2020 | share | Increase | +4.97% | 49.59K shares | 773K | $26.28 | 1.04M |
| Q2 2020 | share | Increase | +22.27% | 181.55K shares | 12.59M | $26.81 | 996.87K |
| Q1 2020 | share | Increase | +0.01% | 47 shares | -324K | $17.99 | 815.31K |
| Q4 2019 | share | Increase | +25.99% | 168.19K shares | 4.41M | $17.73 | 815.27K |
| Q3 2019 | share | Increase | +6.06% | 37K shares | -399K | $15.51 | 647.07K |
| Q2 2019 | share | Increase | +3.30% | 19.5K shares | 926K | $17.18 | 610.07K |
| Q1 2019 | share | Increase | +113.21% | 313.57K shares | 5.45M | $16.1 | 590.57K |
| Q4 2018 | share | Increase | +73.13% | 117K shares | 1.14M | $14.63 | 277K |
| Q3 2018 | share | Increase | +8.84% | 13K shares | 427K | $18.17 | 160K |
| Q2 2018 | share | Increase | +20.49% | 25K shares | 90K | $16.87 | 147K |
| Q1 2018 | share | Decrease | -10.29% | -14K shares | -365K | $19.59 | 122K |
| Q4 2017 | share | Decrease | -14.47% | -23K shares | -7K | $20.26 | 136K |
| Q3 2017 | share | Decrease | -34.30% | -83K shares | -341K | $17.37 | 159K |
| Q2 2017 | share | Increase | +11.52% | 25K shares | 291K | $12.82 | 242K |
| Q1 2017 | share | Decrease | -36.18% | -123K shares | -547K | $12.96 | 217K |
| Q4 2016 | share | Increase | +29.77% | 78K shares | 194K | $9.88 | 340K |
| Q3 2016 | share | Increase | +29.70% | 60K shares | 1.42M | $12.08 | 262K |
| Q2 2016 | share | Decrease | -12.93% | -30K shares | -442K | $8.63 | 202K |
| Q1 2016 | share | Increase | +5.17% | 11.4K shares | -1.63M | $9.47 | 232K |